{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T07:12:29Z","timestamp":1781248349282,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s10549-025-07784-6","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T13:35:27Z","timestamp":1752845727000},"page":"281-289","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical subtypes and prognosis of invasive breast cancer with Paget\u2019s disease: a SEER study"],"prefix":"10.1007","volume":"213","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0551-7618","authenticated-orcid":false,"given":"Soo Youn","family":"Bae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chai Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehyun","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Ah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dooreh","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Joo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Ik","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Chan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"key":"7784_CR1","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/bjs.1800780627","volume":"78","author":"AR Dixon","year":"1991","unstructured":"Dixon AR, Galea MH, Ellis IO, Elston CW, Blamey RW (1991) Paget\u2019s disease of the nipple. Br J Surg 78:722\u2013723. https:\/\/doi.org\/10.1002\/bjs.1800780627","journal-title":"Br J Surg"},{"key":"7784_CR2","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10549-007-9880-5","volume":"112","author":"M Caliskan","year":"2008","unstructured":"Caliskan M et al (2008) Paget\u2019s disease of the breast: the experience of the European Institute of Oncology and review of the literature. Breast Cancer Res Treat 112:513\u2013521. https:\/\/doi.org\/10.1007\/s10549-007-9880-5","journal-title":"Breast Cancer Res Treat"},{"key":"7784_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.4103\/1477-3163.90676","volume":"10","author":"C Karakas","year":"2011","unstructured":"Karakas C (2011) Paget\u2019s disease of the breast. J Carcinog 10:31. https:\/\/doi.org\/10.4103\/1477-3163.90676","journal-title":"J Carcinog"},{"key":"7784_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1468-3083.2007.02154.x","volume":"21","author":"J Kanitakis","year":"2007","unstructured":"Kanitakis J (2007) Mammary and extramammary Paget\u2019s disease. J Eur Acad Dermatol Venereol 21:581\u2013590. https:\/\/doi.org\/10.1111\/j.1468-3083.2007.02154.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"7784_CR5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/bf02303576","volume":"4","author":"JH Yim","year":"1997","unstructured":"Yim JH, Wick MR, Philpott GW, Norton JA, Doherty GM (1997) Underlying pathology in mammary Paget\u2019s disease. Ann Surg Oncol 4:287\u2013292. https:\/\/doi.org\/10.1007\/bf02303576","journal-title":"Ann Surg Oncol"},{"key":"7784_CR6","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3760\/cma.j.cn112151-20230214-00128","volume":"52","author":"XW Hu","year":"2023","unstructured":"Hu XW et al (2023) Expression of MSI1 and HER2 in mammary Paget\u2019s disease and their correlation with clinicopathological features and prognosis. Zhonghua Bing Li Xue Za Zhi 52:832\u2013837. https:\/\/doi.org\/10.3760\/cma.j.cn112151-20230214-00128","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"7784_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.humpath.2017.12.030","volume":"77","author":"R Mai","year":"2018","unstructured":"Mai R et al (2018) Transcriptome analyses reveal FOXA1 dysregulation in mammary and extramammary Paget\u2019s disease. Hum Pathol 77:152\u2013158. https:\/\/doi.org\/10.1016\/j.humpath.2017.12.030","journal-title":"Hum Pathol"},{"key":"7784_CR8","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1365-2559.1989.tb01610.x","volume":"15","author":"GA Lammie","year":"1989","unstructured":"Lammie GA, Barnes DM, Millis RR, Gullick WJ (1989) An immunohistochemical study of the presence of c-erbB-2 protein in Paget\u2019s disease of the nipple. Histopathology 15:505\u2013514. https:\/\/doi.org\/10.1111\/j.1365-2559.1989.tb01610.x","journal-title":"Histopathology"},{"key":"7784_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1365-2559.1990.tb00714.x","volume":"17","author":"L Keatings","year":"1990","unstructured":"Keatings L et al (1990) c-erbB-2 oncoprotein expression in mammary and extramammary Paget\u2019s disease: an immunohistochemical study. Histopathology 17:243\u2013247. https:\/\/doi.org\/10.1111\/j.1365-2559.1990.tb00714.x","journal-title":"Histopathology"},{"key":"7784_CR10","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1365-2559.2010.03665.x","volume":"57","author":"P Sek","year":"2010","unstructured":"Sek P, Zawrocki A, Biernat W, Piekarski JH (2010) HER2 molecular subtype is a dominant subtype of mammary Paget\u2019s cells An immunohistochemical study. Histopathology 57:564\u2013571. https:\/\/doi.org\/10.1111\/j.1365-2559.2010.03665.x","journal-title":"Histopathology"},{"key":"7784_CR11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1365-2559.2007.02633.x","volume":"50","author":"B Liegl","year":"2007","unstructured":"Liegl B et al (2007) Mammary and extramammary Paget\u2019s disease: an immunohistochemical study of 83 cases. Histopathology 50:439\u2013447. https:\/\/doi.org\/10.1111\/j.1365-2559.2007.02633.x","journal-title":"Histopathology"},{"key":"7784_CR12","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1002\/cam4.1475","volume":"7","author":"Y Zhao","year":"2018","unstructured":"Zhao Y et al (2018) Clinicopathological characteristics and survival outcomes in Paget disease: a SEER population-based study. Cancer Med 7:2307\u20132318. https:\/\/doi.org\/10.1002\/cam4.1475","journal-title":"Cancer Med"},{"key":"7784_CR13","doi-asserted-by":"publisher","first-page":"8319","DOI":"10.2147\/ott.S171710","volume":"11","author":"H Zhou","year":"2018","unstructured":"Zhou H et al (2018) Prognostic significance of mammary Paget\u2019s disease in Chinese women: a 10-year, population-based, matched cohort study. Onco Targets Ther 11:8319\u20138326. https:\/\/doi.org\/10.2147\/ott.S171710","journal-title":"Onco Targets Ther"},{"key":"7784_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2147\/cmar.S338788","volume":"14","author":"BY Han","year":"2022","unstructured":"Han BY et al (2022) Clinicopathological characteristics and survival outcomes of mammary Paget\u2019s disease: a retrospective study based on a Chinese population. Cancer Manag Res 14:237\u2013247. https:\/\/doi.org\/10.2147\/cmar.S338788","journal-title":"Cancer Manag Res"},{"key":"7784_CR15","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/cam4.2820","volume":"9","author":"Z Gatalica","year":"2020","unstructured":"Gatalica Z et al (2020) Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget\u2019s disease. Cancer Med 9:1441\u20131450. https:\/\/doi.org\/10.1002\/cam4.2820","journal-title":"Cancer Med"},{"key":"7784_CR16","first-page":"17","volume":"39","author":"T Lester","year":"2009","unstructured":"Lester T et al (2009) Different panels of markers should be used to predict mammary Paget\u2019s disease associated with in situ or invasive ductal carcinoma of the breast. Ann Clin Lab Sci 39:17\u201324","journal-title":"Ann Clin Lab Sci"},{"key":"7784_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/jso.1090","volume":"77","author":"W Fu","year":"2001","unstructured":"Fu W, Lobocki CA, Silberberg BK, Chelladurai M, Young SC (2001) Molecular markers in Paget disease of the breast. J Surg Oncol 77:171\u2013178. https:\/\/doi.org\/10.1002\/jso.1090","journal-title":"J Surg Oncol"},{"key":"7784_CR18","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1093\/jnci\/92.8.622","volume":"92","author":"VRJ Schelfhout","year":"2000","unstructured":"Schelfhout VRJ et al (2000) Pathogenesis of Paget\u2019s disease: epidermal heregulin-\u03b1, motility factor, and the HER receptor family. JNCI J Nat Cancer Inst 92:622\u2013628. https:\/\/doi.org\/10.1093\/jnci\/92.8.622","journal-title":"JNCI J Nat Cancer Inst"},{"key":"7784_CR19","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10549-019-05490-8","volume":"179","author":"K Drews-Elger","year":"2020","unstructured":"Drews-Elger K et al (2020) Paget\u2019s disease of the nipple in a Her2-positive breast cancer xenograft model. Breast Cancer Res Treat 179:577\u2013584. https:\/\/doi.org\/10.1007\/s10549-019-05490-8","journal-title":"Breast Cancer Res Treat"},{"key":"7784_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12253-009-9179-4","volume":"16","author":"J-C Noel","year":"2010","unstructured":"Noel J-C, Fayt I, Buxant F (2010) Proliferating activity in Paget disease of the nipple. Pathol Oncol Res 16:7\u201310. https:\/\/doi.org\/10.1007\/s12253-009-9179-4","journal-title":"Pathol Oncol Res"},{"key":"7784_CR21","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/1097-0142(19870315)59:6<1173::AID-CNCR2820590624>3.0.CO;2-R","volume":"59","author":"NG Ord\u00f3\u00f1ez","year":"1987","unstructured":"Ord\u00f3\u00f1ez NG, Awalt H, Mackay B (1987) Mammary and extramammary paget\u2019s disease an immunocytochemical and ultrastructural study. Cancer 59:1173\u20131183","journal-title":"Cancer"},{"key":"7784_CR22","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1046\/j.1365-2559.1999.00788.x","volume":"35","author":"KT Mai","year":"1999","unstructured":"Mai KT (1999) Morphological evidence for field effect as a mechanism for tumour spread in mammary Paget\u2019s disease. Histopathology 35:567\u2013576. https:\/\/doi.org\/10.1046\/j.1365-2559.1999.00788.x","journal-title":"Histopathology"},{"key":"7784_CR23","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1002\/cam4.2242","volume":"8","author":"S Chen","year":"2019","unstructured":"Chen S et al (2019) Comparative study of breast cancer with or without concomitant Paget disease: An analysis of the SEER database. Cancer Med 8:4043\u20134054. https:\/\/doi.org\/10.1002\/cam4.2242","journal-title":"Cancer Med"},{"key":"7784_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-013-2661-4","volume":"141","author":"AC Sandoval-Leon","year":"2013","unstructured":"Sandoval-Leon AC, Drews-Elger K, Gomez-Fernandez CR, Yepes MM, Lippman ME (2013) Paget\u2019s disease of the nipple. Breast Cancer Res Treat 141:1\u201312. https:\/\/doi.org\/10.1007\/s10549-013-2661-4","journal-title":"Breast Cancer Res Treat"},{"key":"7784_CR25","first-page":"49","volume":"57","author":"RW Sagebiel","year":"1969","unstructured":"Sagebiel RW (1969) Ultrastructural observations on epidermal cells in Paget\u2019s disease of the breast. Am J Pathol 57:49\u201364","journal-title":"Am J Pathol"},{"key":"7784_CR26","first-page":"173","volume":"14","author":"S Sagami","year":"1963","unstructured":"Sagami S (1963) Electron microscopic studies in Paget\u2019s disease. Med J Osaka Univ 14:173\u2013188","journal-title":"Med J Osaka Univ"},{"key":"7784_CR27","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1136\/jclinpath-2014-202280","volume":"67","author":"D Saeed","year":"2014","unstructured":"Saeed D, Shousha S (2014) Toker cells of the nipple are commonly associated with underlying sebaceous glands but not with lactiferous ducts. J Clin Pathol 67:1010\u20131012. https:\/\/doi.org\/10.1136\/jclinpath-2014-202280","journal-title":"J Clin Pathol"},{"key":"7784_CR28","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.humpath.2008.01.018","volume":"39","author":"L Di Tommaso","year":"2008","unstructured":"Di Tommaso L et al (2008) Toker cells of the breast. Morphological and immunohistochemical characterization of 40 cases. Hum Pathol 39:1295\u20131300. https:\/\/doi.org\/10.1016\/j.humpath.2008.01.018","journal-title":"Hum Pathol"},{"key":"7784_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00428-001-0581-x","volume":"441","author":"G Marucci","year":"2002","unstructured":"Marucci G et al (2002) Toker cells are probably precursors of Paget cell carcinoma: a morphological and ultrastructural description. Virchows Arch 441:117\u2013123. https:\/\/doi.org\/10.1007\/s00428-001-0581-x","journal-title":"Virchows Arch"},{"key":"7784_CR30","doi-asserted-by":"publisher","first-page":"100121","DOI":"10.1016\/j.modpat.2023.100121","volume":"36","author":"GM Baker","year":"2023","unstructured":"Baker GM et al (2023) Toker cell hyperplasia in the nipple-areolar complex of transmasculine individuals. Mod Pathol 36:100121. https:\/\/doi.org\/10.1016\/j.modpat.2023.100121","journal-title":"Mod Pathol"},{"key":"7784_CR31","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/s0046-8177(03)00405-2","volume":"34","author":"L Morandi","year":"2003","unstructured":"Morandi L et al (2003) Intraepidermal cells of Paget\u2019s carcinoma of the breast can be genetically different from those of the underlying carcinoma. Hum Pathol 34:1321\u20131330. https:\/\/doi.org\/10.1016\/s0046-8177(03)00405-2","journal-title":"Hum Pathol"},{"key":"7784_CR32","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1136\/jcp.53.10.742","volume":"53","author":"J Lloyd","year":"2000","unstructured":"Lloyd J, Flanagan AM (2000) Mammary and extramammary Paget\u2019s disease. J Clin Pathol 53:742\u2013749. https:\/\/doi.org\/10.1136\/jcp.53.10.742","journal-title":"J Clin Pathol"},{"key":"7784_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59010086","author":"FO Alshammari","year":"2022","unstructured":"Alshammari FO et al (2022) Glypican-3 differentiates intraductal carcinoma and Paget\u2019s disease from other types of breast cancer. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina59010086","journal-title":"Medicina (Kaunas)"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07784-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-025-07784-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07784-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T14:15:43Z","timestamp":1757254543000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-025-07784-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["7784"],"URL":"https:\/\/doi.org\/10.1007\/s10549-025-07784-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"8 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}